Application no. and date | 17713672.8 (espacenet) (Federated) (European Patent Register), 20170327 | Patent/reg. no. and date | DK/EP 3433273, 20211229 | Publication date | 20190130 | Priority no. and date | EP 16305350, 20160325 | EP pub. no. and date |
EP 3433273 20190130 | Effective date | | Applicant/owner | Biomunex Pharmaceuticals, 113 rue de la Tour
75116 Paris, FR | Applicant ref. no. | P78949DK01 | Inventor | Leger, Olivier, 603 route des Luches
74800 Saint Sixt, FR, ZHUKOVSKY, Eugene, 5 Avenue Frémiet
75016 Paris, FR, MORSE, Richard J., 5 Avenue Fremiet
75016 Paris, FR | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/00 (2006.01) , C07K 16/28 (2006.01) | Title | BINDING AF MOLEKYLER TIL CD38 OG PD-L1 | Int. application no. | EP2017057220 | Int. publication no. | WO2017162890 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|